PO-0918: Radiotherapy and Her2 targeting agents: synergism and antagonism in clonogenic and confluence assays. (May 2017) - Suchowerska, N.; Toohey, J.; Carroll, S.; Rogers, L.; Lyons, G.; Beith, J.; Dos Santos Esteves, A.; McKenzie, D.R.